Europe Immunochemistry Market to 2027- Regional Analysis and Forecasts by Application (Diagnostics, Drug Testing); Product (Antibodies, Equipment, Reagents, Kits); End User (Hospitals and Diagnostic Laboratories, Research Institutes, Others), and Country

TIPRE00008334 | Pages: 180 | Biotechnology | Jan 2020 | Type: Regional | Status: Published

The Europe immunochemistry market is expected to reach US$ 775.97 Mn in 2027 from US$ 430.82 Mn in 2018. The market is estimated to grow with a CAGR of 6.9% from 2019-2027.

 

The growth of the market is driven by the factors such as, significantly increasing prevalence of cardiovascular diseases and rising incidence of diabetes. However, the market is likely to slower down its growth due to the shortage of skilled professionals.

 

The healthcare industry has been observing rapid transformations during the previous years. Various technological improvements have been witnessed in the segments such as, diagnosis and treatment options for chronic diseases. The increase in incidences of chronic illnesses, ageing population, are the primary factors fuelling the growth of healthcare segment.

 

Germany has a history of manufacturing high diagnostic imaging technologies, precision medical instruments and others. There has been an increase in the healthcare expenditure in the European countries during the previous years. As per Eurostat in 2016, healthcare expenditure in Germany was EUR 352 billion. Medical technologies is the priority of Healthcare/Life Sciences (HCT) industry. Whereas the healthcare expenditure of France was recorded as the second highest which was around EUR 257 billion, followed by the United Kingdom EUR 234 billion.

The above mentioned factors are expected to offer broad growth opportunities in the healthcare industry and this is expected to cause the demand for immunochemistry assays in the market.

 

Germany is expected to lead the market in the Europe region owing to the factors such as an increase in the number of cancer cases, the higher prevalence of the diseases, government initiatives, and investments for the research and development by the government bodies and private entities. Along with the government, private companies are also focusing on the development of the conditions in the country. Therefore, considering the above-mentioned factors the growth of the market in the country is likely to contribute the largest share in the Europe region during the forecast period.

 

Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Europe Immunohistochemistry Market

Get more information on this report :


 

EUROPE IMMUNOHISTOCHEMISTRY – MARKET SEGMENTATION

By Product

  • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
  • Equipment
    • Slide Staining Systems
    • Tissue Microarray Systems
    • Slide Scanners
    • Other Equipment
  • Reagents
    • Histological Stains
    • Blocking and Fixation Reagents
    • Chromogenic Substrates
    • Stabilizers
    • Solvents
    • Proteolytic Enzymes
  • Kits

 

By Application

  • Diagnostics
    • Cancer
    • Infectious Diseases
    • Autoimmune Diseases
    • Diabetes Mellitus
    • Nephrological Diseases
  • Drug Testing

 

By End User

  • Hospitals and Diagnostic Laboratories
  • Research Institutes
  • Others

 

By Geography

  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy

 

Company Profiles

  • PerkinElmer, Inc.
  • Abcam Plc
  • Agilent Technologies,
  • Bio SB
  • Bio-Rad Laboratories, Inc.
  • Cell Signalling Technology, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Danaher
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

2.           Europe Immunochemistry Market– Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Immunochemistry Market – Market Landscape

4.1         Overview

4.2         Market Segmentation

4.2.1        Europe Immunochemistry Market – By Product

4.2.2        Europe Immunochemistry Market – By Application

4.2.3        Europe Immunochemistry Market – By End User

4.2.4        Europe Immunochemistry Market – By Country

4.3         PEST Analysis

5.           Europe Immunochemistry Market - Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Significantly Increasing Prevalence of Cardiovascular Diseases

5.1.2        Rising Incidence of Diabetes

5.2         Key Market Restraints

5.2.1        Shortage of Skilled Professionals

5.3         Key Market Opportunities

5.3.1        Rising Healthcare Expenditure in Europe

5.4         Future Trends

5.4.1        Rising Future Conferences and Workshops

5.5         Impact Analysis

6.           Immunochemistry Market – Europe Analysis

6.1         Europe Immunochemistry Market Revenue Forecasts And Analysis

6.2         Performance of Key Players

7.           Europe Immunochemistry Market Analysis – By Application

7.1         Overview

7.2         Europe Immunochemistry Market, By Application, 2018 & 2027 (%)

7.3         Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

7.3.1.1          Europe Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

7.4         Diagnostics

7.4.1        Overview

7.4.2        Europe Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

7.4.3        Cancer

7.4.3.1          Overview

7.4.3.2          Europe Cancer Market Revenue and Forecast to 2027 (US$ Mn)

7.4.4        Infectious Diseases

7.4.4.1          Overview

7.4.4.2          Europe Infectious Diseases Market Revenue and Forecast to 2027 (US$ Mn)

7.4.5        Autoimmune Diseases

7.4.5.1          Overview

7.4.5.2          Europe Autoimmune Diseases Market Revenue and Forecast to 2027 (US$ Mn)

7.4.6        Nephrological Diseases

7.4.6.1          Overview

7.4.6.2          Europe Nephrological Diseases Market Revenue and Forecast to 2027 (US$ Mn)

7.5         Drug Testing

7.5.1        Overview

7.5.2        Europe Drug Testing Market Revenue and Forecast to 2027 (US$ Mn)

8.           Europe Immunochemistry Market Analysis – By Product

8.1         Overview

8.2         Europe Immunochemistry Market, By Product, 2018 & 2027 (%)

8.3         Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.3.1        Europe Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.2        Europe Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.3        Europe Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.4         Antibodies Market

8.4.1        Overview

8.4.2        Europe Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.3        Primary Antibodies

8.4.3.1          Overview

8.4.3.2          Europe Primary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.4        Secondary Antibodies

8.4.4.1          Overview

8.4.4.2          Europe Secondary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)

8.5         Equipment

8.5.1        Overview

8.5.2        Europe Equipment Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.3        Slide Staining Systems

8.5.3.1          Overview

8.5.3.2          Europe Slide Staining Systems Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.4        Tissue Microarrays

8.5.4.1          Overview

8.5.4.2          Europe Tissue Microarrays Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.5        Slide Scanners

8.5.5.1          Overview

8.5.5.2          Europe Slide Scanners Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.6        Other Equipment

8.5.6.1          Overview

8.5.6.2          Europe Other Equipment Market Revenue and Forecasts to 2027 (US$ Mn)

8.6         Reagents

8.6.1        Overview

8.6.2        Europe Reagents Market Revenue and Forecasts to 2027 (US$ Mn)

8.6.3        Histological Stains

8.6.3.1          Overview

8.6.3.2          Europe Histological Stains Market Revenue and Forecasts to 2027 (US$ Mn)

8.6.4        Blocking & Fixation Reagents

8.6.4.1          Overview

8.6.4.2          Europe Blocking & Fixation Reagents Market Revenue and Forecasts to 2027 (US$ Mn)

8.6.5        Chromogenic Substrates

8.6.5.1          Overview

8.6.5.2          Europe Chromogenic Substrates Market Revenue and Forecasts to 2027 (US$ Mn)

8.6.6        Stabilizers

8.6.6.1          Overview

8.6.6.2          Europe Stabilizers Market Revenue and Forecasts to 2027 (US$ Mn)

8.6.7        Proteolytic Enzymes

8.6.7.1          Overview

8.6.7.2          Europe Proteolytic Enzymes Market Revenue and Forecasts to 2027 (US$ Mn)

8.6.8        Solvents

8.6.8.1          Overview

8.6.8.2          Europe Solvents Market Revenue and Forecasts to 2027 (US$ Mn)

8.7         Kits

8.7.1        Overview

8.7.2        Europe Kits Market Revenue and Forecasts to 2027 (US$ Mn)

9.           Europe Immunochemistry Market Analysis – By End User

9.1         Overview

9.2         Europe Immunochemistry Market, By End User, 2018 & 2027 (%)

9.3         Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.4         Hospital & Diagnostic Laboratories

9.4.1        Overview

9.4.2        Europe Hospital & Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

9.5         Research Institutes

9.5.1        Overview

9.5.2        Europe Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)

9.6         Others End Users

9.6.1        Overview

9.6.2        Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

10.        Europe Immunochemistry Market Revenue and Forecasts To 2027

10.1      Overview

10.1.1     Europe Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.2     Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.1.2.1       Europe Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.3     Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.3.1       Europe Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.3.2       Europe Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.3.3       Europe Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.4     Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.5     Europe Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%)

10.1.6     UK Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.6.1       UK Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.6.2       UK Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.1.6.2.1       UK Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.6.3       UK Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.6.3.1       UK Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.6.3.2       UK Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.6.3.3       UK Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.6.4       UK Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.7     Germany Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.7.1       Germany Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.7.2       Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.1.7.2.1       Germany Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.7.3       Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.7.3.1       Germany Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.7.3.2       Germany Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.7.3.3       Germany Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.7.4       Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.8     France Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8.1       France Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8.2       France Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.1.8.2.1       France Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.8.3       France Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.8.3.1       France Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.8.3.2       France Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.8.3.3       France Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.8.4       France Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.9     Italy Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.9.1       Italy Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.9.2       Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.1.9.2.1       Italy Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.9.3       Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.9.3.1       Italy Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.9.3.2       Italy Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.9.3.3       Italy Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.9.4       Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.10  Spain Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.10.1    Spain Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.10.2    Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.1.10.2.1    Spain Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.10.3    Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.10.3.1    Spain Antibodies Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.10.3.2    Spain Equipment Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.10.3.3    Spain Reagents Market Revenue And Forecasts To 2027, By Type (US$ MN)

10.1.10.4    Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.        Immunochemistry Market – Industry Landscape

11.1      Overview

11.2      Growth Strategies done by the companies in the Market, 2018 (%)

11.3      Organic Developments

11.3.1     Overview

11.4      Inorganic developments

11.4.1     Overview

12.        Immunohistochemistry Market–Key Company Profiles

12.1      Bio SB

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Financial Overview

12.1.4     Product portfolio

12.1.5     SWOT ANALYSIS

12.1.6     Key Developments

12.2      Cell Signaling Technology, Inc.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Financial Overview

12.2.4     Product portfolio

12.2.5     SWOT ANALYSIS

12.2.6     Key Developments

12.3      F. Hoffmann-La Roche Ltd.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Financial Overview

12.3.4     Product Portfolio

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Merck KGaA

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Financial Overview

12.4.4     Product Portfolio

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      PerkinElmer, Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Financial Overview

12.5.4     Product Portfolio

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Thermo Fisher Scientific, Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Financial Overview

12.6.4     Product Portfolio

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Abcam Plc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Financial Overview

12.7.4     Product Portfolio

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Agilent Technologies, Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Financial Overview

12.8.4     Product Portfolio

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Bio-Rad Laboratories, Inc.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Financial Information

12.9.4     Product Portfolio

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Danaher

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Financial Information

12.10.4  Product Portfolio

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary Of Terms

 

LIST OF TABLES

Table 1.             Prevalence Of Diabetes In The Region, 2017. 42

Table 2.             Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn) 50

Table 3.             Europe Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn) 50

Table 4.             Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn) 63

Table 5.             Europe Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn) 63

Table 6.             Europe Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn) 64

Table 7.             Europe Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn) 64

Table 8.             Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn) 94

Table 9.             Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn) 103

Table 10.          Europe Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn) 104

Table 11.          Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn) 104

Table 12.          Europe Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn) 105

Table 13.          Europe Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn) 105

Table 14.          Europe Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn) 106

Table 15.          Europe Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn) 106

Table 16.          UK Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn) 109

Table 17.          UK Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn) 109

Table 18.          UK Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn) 110

Table 19.          UK Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn) 111

Table 20.          UK Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn) 111

Table 21.          UK Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn) 112

Table 22.          UK Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn) 112

Table 23.          Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn) 115

Table 24.          Germany Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn) 115

Table 25.          Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn) 115

Table 26.          Germany Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn) 116

Table 27.          Germany Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn) 116

Table 28.          Germany Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn) 117

Table 29.          Germany Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn) 117

Table 30.          France Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn) 119

Table 31.          France Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn) 120

Table 32.          France Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn) 120

Table 33.          France Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn) 121

Table 34.          France Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn) 121

Table 35.          France Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn) 122

Table 36.          France Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn) 122

Table 37.          Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn) 125

Table 38.          Italy Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn) 125

Table 39.          Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn) 126

Table 40.          Italy Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn) 126

Table 41.          Italy Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn) 127

Table 42.          Italy Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn) 127

Table 43.          Italy Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn) 128

Table 44.          Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By Application (US$ Mn) 130

Table 45.          Spain Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn) 131

Table 46.          Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By Product (US$ Mn) 131

Table 47.          Spain Antibodies Market Revenue And Forecasts to 2027, By Type (US$ Mn) 132

Table 48.          Spain Equipment Market Revenue And Forecasts to 2027, By Type (US$ Mn) 132

Table 49.          Spain Reagents Market Revenue And Forecasts to 2027, By Type (US$ Mn) 133

Table 50.          Spain Immunohistochemistry Market Revenue And Forecasts to 2027, By End User (US$ Mn) 133

Table 1.             Organic Developments Done By Companies. 135

Table 2.             Inorganic developments done by Companies. 136

Table 3.             Glossary Of Terms, Immunochemistry Market 175

 

LIST OF FIGURES

Figure 1.           Europe Immunochemistry Market Overview.. 24

Figure 2.           Germany is Expected To Show Remarkable Growth During The Forecast Period. 26

Figure 3.           Europe Immunochemistry Market- Leading Country Markets (US$ Mn) 28

Figure 4.           Immunochemistry Market Segmentation. 34

Figure 5.           Europe PEST Analysis. 38

Figure 6.           Immunochemistry Market Impact Analysis of Drivers & Restraints. 45

Figure 7.           Europe Immunochemistry Market – Revenue Forecasts And Analysis – 2018- 2027. 47

Figure 8.           Prominent Players in the Immunohistochemistry Market 48

Figure 9.           Europe Immunochemistry Market, By Application, 2018 & 2027 (%) 49

Figure 10.        Europe Diagnostics Market Revenue And Forecasts To 2027 (US$ Mn) 52

Figure 11.        Europe Cancer Market Revenue And Forecasts To 2027 (US$ Mn) 53

Figure 12.        Europe Infectious Diseases Market Revenue And Forecasts To 2027 (US$ Mn) 55

Figure 13.        Europe Autoimmune Diseases Market Revenue And Forecasts To 2027 (US$ Mn) 57

Figure 14.        Europe Nephrological Diseases Market Revenue And Forecasts To 2027 (US$ Mn) 59

Figure 15.        Europe Drug Testing Market Revenue And Forecasts To 2027 (US$ Mn) 60

Figure 16.        Europe Immunochemistry Market, By Product 2018 & 2027 (%) 62

Figure 17.        Europe Antibodies Market Revenue and Forecasts to 2027 (US$ Mn) 65

Figure 18.        Europe Primary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn) 67

Figure 19.        Europe Secondary Antibodies Market Revenue and Forecasts to 2027 (US$ Mn) 68

Figure 20.        Europe Equipment Market Revenue and Forecasts to 2027 (US$ Mn) 70

Figure 21.        Europe Slide Staining Systems Market Revenue and Forecasts to 2027 (US$ Mn) 72

Figure 22.        Europe Tissue Microarrays Market Revenue and Forecasts to 2027 (US$ Mn) 74

Figure 23.        Europe Slide Scanners Market Revenue and Forecasts to 2027 (US$ Mn) 75

Figure 24.        Europe Other Equipment Market Revenue and Forecasts to 2027 (US$ Mn) 77

Figure 25.        Europe Reagents Market Revenue and Forecasts to 2027 (US$ Mn) 79

Figure 26.        Europe Histological Stains Market Revenue and Forecasts to 2027 (US$ Mn) 81

Figure 27.        Europe Blocking & Fixation Reagents Market Revenue and Forecasts to 2027 (US$ Mn) 82

Figure 28.        Europe Chromogenic Substrates Market Revenue and Forecasts to 2027 (US$ Mn) 84

Figure 29.        Europe Stabilizers Market Revenue and Forecasts to 2027 (US$ Mn) 86

Figure 30.        Europe Proteolytic Enzymes Market Revenue and Forecasts to 2027 (US$ Mn) 88

Figure 31.        Europe Solvents Market Revenue and Forecasts to 2027 (US$ Mn) 89

Figure 32.        Europe Kits Market Revenue and Forecasts to 2027 (US$ Mn) 91

Figure 33.        Europe Immunochemistry Market, By End User, 2018 & 2027 (%) 93

Figure 34.        Europe Hospital & Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn) 96

Figure 35.        Europe Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn) 97

Figure 36.        Europe Others Market Revenue and Forecasts to 2027 (US$ Mn) 99

Figure 37.        Europe Immunohistochemistry Market Revenue Overview, by Country (2018) (US$ Mn) 101

Figure 38.        Europe Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn) 103

Figure 39.        Europe Immunohistochemistry Market Revenue and Forecasts to 2027, By Country (%) 107

Figure 40.        UK Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn) 108

Figure 41.        Germany Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn) 114

Figure 42.        France Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn) 119

Figure 43.        Italy Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn) 124

Figure 44.        Spain Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn) 129

Figure 45.        Growth Strategies done by the companies in the Market, 2018 (%) 134

 

. 175 133

The List of Companies - Europe Immunochemistry Market

 

  1. PerkinElmer, Inc.
  2. Abcam Plc
  3. Agilent Technologies,
  4. Bio SB
  5. Bio-Rad Laboratories, Inc.
  6. Cell Signalling Technology, Inc.
  7. F. Hoffmann-La Roche Ltd.
  8. Danaher
  9. Merck KGaA
  10. Thermo Fisher Scientific, Inc.

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe immunochemistry market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the Europe immunochemistry market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000